The Anglo-Swiss pharmaceutical firm Astrazeneca has rejected a new takeover bid from Pfizer, worth almost $119 billion. Pfizer says it won’t improve its offer further, nor will it proceed to a hostile takeover by approaching shareholders directly. Also today: Nutella, the staple of French breakfast tables, celebrates its 50th birthday.
